CD274 and cancer: Certain amount of Th17 cells were observed in the spleen of anti-PD-L1 mAb and OxP+anti-PD-L1 mAb treatment groups (Fig. 3e), suggesting the possibility of irAEs when applying systematically injected anti-PD-L1 mAb in cancer therapy.